reduce insulin dose when starting glp-1 receptor agonist Drugs and Type 1 Diabetes: Less Insulin, Better Time in Range — What the Evidence Ten Top Tips for the

The berberine and semaglutide combination has gained attention as a way to enhance GLP-1 effects naturally

Newer agents appear to be more effective at A1c and weight lowering, and its a very exciting time for the treatment of type 2 diabetes and obesity when the new GLP-1 agonists are able to achieve more robust A1c lowering than any other existing diabetes medication other than insulin, she told Healthline

For instance, in January 2025, the FDA approved semaglutide (Ozempic) as a medication to reduce the risk of kidney failure, kidney disease progression, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease (CKD)

In addition to regulating apoptosis, GLP-1RAs also fine-tune mitochondrial quality control via mitophagy

Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimers disease